Manulife (Manufacturers Life Insurance)’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.53M | Buy |
124,546
+29,761
| +31% | +$606K | ﹤0.01% | 1411 |
|
|
2025
Q1 | $1.72M | Sell |
94,785
-9,591
| -9% | -$174K | ﹤0.01% | 1548 |
|
|
2024
Q4 | $2.64M | Sell |
104,376
-1,401
| -1% | -$35.4K | ﹤0.01% | 1445 |
|
|
2024
Q3 | $3.6M | Sell |
105,777
-24,010
| -18% | -$816K | ﹤0.01% | 1351 |
|
|
2024
Q2 | $4.8M | Buy |
129,787
+243
| +0.2% | +$8.99K | ﹤0.01% | 1183 |
|
|
2024
Q1 | $5.44M | Buy |
129,544
+86,117
| +198% | +$3.61M | 0.01% | 1157 |
|
|
2023
Q4 | $1.72M | Sell |
43,427
-6,405
| -13% | -$254K | ﹤0.01% | 1522 |
|
|
2023
Q3 | $1.37M | Buy |
49,832
+4,666
| +10% | +$128K | ﹤0.01% | 1567 |
|
|
2023
Q2 | $1.53M | Sell |
45,166
-15,912
| -26% | -$540K | ﹤0.01% | 1491 |
|
|
2023
Q1 | $2.2M | Buy |
61,078
+2,427
| +4% | +$87.3K | ﹤0.01% | 1376 |
|
|
2022
Q4 | $2.63M | Buy |
58,651
+4,187
| +8% | +$188K | ﹤0.01% | 1313 |
|
|
2022
Q3 | $1.54M | Buy |
54,464
+4,331
| +9% | +$122K | ﹤0.01% | 1452 |
|
|
2022
Q2 | $1.38M | Sell |
50,133
-13,378
| -21% | -$368K | ﹤0.01% | 1514 |
|
|
2022
Q1 | $2.19M | Buy |
63,511
+40,225
| +173% | +$1.39M | ﹤0.01% | 1476 |
|
|
2021
Q4 | $903 | Sell |
23,286
-93
| -0.4% | -$4 | ﹤0.01% | 1899 |
|
|
2021
Q3 | $1.26M | Buy |
23,379
+1,244
| +6% | +$67.2K | ﹤0.01% | 1692 |
|
|
2021
Q2 | $740K | Buy |
+22,135
| New | +$740K | ﹤0.01% | 2168 |
|
|
2018
Q3 | – | Sell |
-273
| Closed | -$2K | – | 3077 |
|
|
2018
Q2 | $2K | Sell |
273
-6,581
| -96% | -$48.2K | ﹤0.01% | 4196 |
|
|
2018
Q1 | $239K | Sell |
6,854
-121
| -2% | -$4.22K | ﹤0.01% | 2882 |
|
|
2017
Q4 | $297K | Buy |
6,975
+384
| +6% | +$16.4K | ﹤0.01% | 2709 |
|
|
2017
Q3 | $283K | Sell |
6,591
-45
| -0.7% | -$1.93K | ﹤0.01% | 2701 |
|
|
2017
Q2 | $246K | Buy |
6,636
+1,424
| +27% | +$52.8K | ﹤0.01% | 2844 |
|
|
2017
Q1 | $282K | Buy |
5,212
+608
| +13% | +$32.9K | ﹤0.01% | 2590 |
|
|
2016
Q4 | $244K | Buy |
4,604
+79
| +2% | +$4.19K | ﹤0.01% | 2631 |
|
|
2016
Q3 | $275K | Buy |
4,525
+73
| +2% | +$4.44K | ﹤0.01% | 2534 |
|
|
2016
Q2 | $294K | Buy |
4,452
+58
| +1% | +$3.83K | ﹤0.01% | 2405 |
|
|
2016
Q1 | $237K | Buy |
4,394
+81
| +2% | +$4.37K | ﹤0.01% | 2481 |
|
|
2015
Q4 | $1.02K | Buy |
4,313
+44
| +1% | +$10 | ﹤0.01% | 1620 |
|
|
2015
Q3 | $675 | Sell |
4,269
-7,142
| -63% | -$1.13K | ﹤0.01% | 1810 |
|
|
2015
Q2 | $4.32K | Buy |
11,411
+224
| +2% | +$85 | 0.01% | 1125 |
|
|
2015
Q1 | $4.68K | Sell |
11,187
-2,998
| -21% | -$1.25K | 0.01% | 1072 |
|
|
2014
Q4 | $3.88K | Buy |
14,185
+10,303
| +265% | +$2.82K | 0.01% | 1088 |
|
|
2014
Q3 | $754 | Buy |
3,882
+86
| +2% | +$17 | ﹤0.01% | 1741 |
|
|
2014
Q2 | $929K | Sell |
3,796
-665
| -15% | -$163K | ﹤0.01% | 1629 |
|
|
2014
Q1 | $1.18K | Sell |
4,461
-8,827
| -66% | -$2.34K | ﹤0.01% | 1528 |
|
|
2013
Q4 | $4.83K | Sell |
13,288
-79
| -0.6% | -$29 | 0.01% | 1028 |
|
|
2013
Q3 | $7.1K | Sell |
13,367
-241
| -2% | -$128 | 0.01% | 783 |
|
|
2013
Q2 | $3.19M | Buy |
+13,608
| New | +$3.19M | 0.01% | 1084 |
|